Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
Condition(s):Bacterial VaginosisLast Updated:November 25, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Bacterial VaginosisLast Updated:November 25, 2009Completed
Condition(s):Simulation TrainingLast Updated:May 9, 2017Completed
Condition(s):Postoperative MorbidityLast Updated:April 19, 2017Completed
Condition(s):HealthyLast Updated:June 23, 2015Completed
Condition(s):Breast Cancer; Colorectal Cancer; Gallbladder Cancer; Gastric Cancer; Head and Neck Cancer; Liver Cancer; Ovarian Cancer; Pancreatic Cancer; Testicular Germ Cell TumorLast Updated:September 8, 2014Completed
Condition(s):Lung Cancer; Breast Cancer; Prostate Cancer; Tumors (Others); Ovarian CancerLast Updated:October 23, 2020Completed
Condition(s):Performance Assessment; Motion MetricsLast Updated:March 25, 2013Completed
Condition(s):Autism Spectrum DisordersLast Updated:August 25, 2016Withdrawn
Condition(s):Educational ProblemsLast Updated:May 2, 2018Completed
Condition(s):OsteoarthrosisLast Updated:March 31, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.